An mRNA vaccine, a cousin to the COVID vaccines that blunted the pandemic, has entered human trials as a treatment for lung ...

Katalin Karikó, a Nobel Prize laureate, Penn professor, and renowned mRNA researcher from Abington, has been inducted into ...

According to an infectious disease expert, Hong Kong’s flu season is expected to start in December; it is likely to have two ...

Prenatal gene therapy via mRNA LNPs fixes faulty genes in fetal brain cells in animal model of neurodevelopmental syndrome.

New research underscores the role of the immune system in depression, linking inflammation to poor response to standard ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Moderna shares rebound after six days of losses. Analysts mixed on stock with Strong Sell rating but potential for future growth.

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Montréal and UK-based startup Epitopea has raised $31 million USD ($43 million CAD) in what it called pre-Series A funding ...

The science behind vaccines is based on the fundamental principle of training the immune system to recognize and fight ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent patients aged 5 years and older.